Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02OJQ
|
||||
Former ID |
DNC004724
|
||||
Drug Name |
Des-AA1,2,5-[D-Trp8,Tyr11]SRIF
|
||||
Indication | Discovery agent | Investigative | [527384] | ||
Structure |
Download2D MOL |
||||
Formula |
C67H90N14O16S2
|
||||
Canonical SMILES |
CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O<br />)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=C<br />C=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CCCCN)N)C(=O)O)CO)C(C)O<br />)CC6=CC=C(C=C6)O)O
|
||||
InChI |
1S/C67H90N14O16S2/c1-37(83)55-65(94)77-51(31-41-23-25-43(85)26-24-41)63(92)81-56(38(2)84)66(95)78-53(34-82)64(93)79-54(67(96)97)36-99-98-35-45(70)57(86)72-47(21-11-13-27-68)58(87)74-49(29-39-15-5-3-6-16-39)60(89)75-50(30-40-17-7-4-8-18-40)61(90)76-52(32-42-33-71-46-20-10-9-19-44(42)46)62(91)73-48(59(88)80-55)22-12-14-28-69/h3-10,15-20,23-26,33,37-38,45,47-56,71,82-85H,11-14,21-22,27-32,34-36,68-70H2,1-2H3,(H,72,86)(H,73,91)(H,74,87)(H,75,89)(H,76,90)(H,77,94)(H,78,95)(H,79,93)(H,80,88)(H,81,92)(H,96,97)/t37-,38-,45-,47-,48+,49-,50+,51+,52+,53+,54+,55-,56-/m1/s1
|
||||
InChIKey |
NIVBKEGMFSFLSD-KGVPGVLISA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor type 2 | Target Info | Inhibitor | [527384] | |
Somatostatin receptor type 4 | Target Info | Inhibitor | [527384] | ||
Somatostatin receptor 1 | Target Info | Inhibitor | [527384] | ||
Somatostatin receptor type 3 | Target Info | Inhibitor | [527384] | ||
Somatostatin receptor type 5 | Target Info | Inhibitor | [527384] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
PathWhiz Pathway | Gastric Acid Production | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
GPCRs, Class A Rhodopsin-like | |||||
Peptide GPCRs | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP455:GPCRs, Class A Rhodopsin-like | |||||
GPCR downstream signalingWP706:SIDS Susceptibility Pathways | |||||
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.